We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$15B
AUM Growth
+$614M
Cap. Flow
-$689M
Cap. Flow %
-4.6%
Top 10 Hldgs %
9.86%
Holding
499
New
33
Increased
63
Reduced
287
Closed
34

Top Sells

Rank Stock Value
1
PODD icon
Insulet
PODD
+$86.4M
2
SAGE
Sage Therapeutics
SAGE
+$56.2M
3
WEC icon
WEC Energy
WEC
+$49.5M
4
AOS icon
A.O. Smith
AOS
+$48.9M
5
CHRW icon
C.H. Robinson
CHRW
+$41.8M

Sector Composition

Rank Sector Weight
1 Technology 21.48%
2 Healthcare 17.37%
3 Industrials 15.16%
4 Consumer Discretionary 13.51%
5 Financials 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMT icon
351
American Tower
AMT
$80.8B
$8.18M 0.05%
35,600
+3,700
+12% +$806K
CRM icon
352
Salesforce
CRM
$151B
$7.94M 0.05%
48,800
-3,300
-6% -$517K
EG icon
353
Everest Group
EG
$14.5B
$7.93M 0.05%
28,650
-69,425
-71% -$18.3M
LHCG
354
DELISTED
LHC Group LLC
LHCG
$7.92M 0.05%
57,458
-1,900
-3% -$236K
BRKR icon
355
Bruker
BRKR
$9.57B
$7.84M 0.05%
153,742
-15,400
-9% -$733K
PFGC icon
356
Performance Food Group
PFGC
$18B
$7.5M 0.05%
145,638
-4,800
-3% -$219K
CSL icon
357
Carlisle Companies
CSL
$14.3B
$7.44M 0.05%
+45,975
New +$7.09M
MNRO icon
358
Monro
MNRO
$383M
$7.41M 0.05%
94,771
-7,500
-7% -$565K
ABBV icon
359
AbbVie
ABBV
$443B
$7.33M 0.05%
82,800
-6,000
-7% -$498K
SMTC icon
360
Semtech
SMTC
$11B
$7.16M 0.05%
135,296
-8,400
-6% -$421K
NSP icon
361
Insperity
NSP
$1.93B
$7.16M 0.05%
83,174
+8,700
+12% +$757K
PD icon
362
PagerDuty
PD
$816M
$7.12M 0.05%
304,415
-400
-0.1% -$9.84K
CNS icon
363
Cohen & Steers
CNS
$4.23B
$7.09M 0.05%
112,909
-4,100
-4% -$259K
USPH icon
364
US Physical Therapy
USPH
$1.2B
$6.96M 0.05%
60,851
-2,000
-3% -$249K
THG icon
365
Hanover Insurance
THG
$8.1B
$6.94M 0.05%
50,750
-43,575
-46% -$5.86M
ZD icon
366
Ziff Davis
ZD
$1.96B
$6.89M 0.05%
84,555
-4,830
-5% -$399K
ALSN icon
367
Allison Transmission
ALSN
$9.5B
$6.81M 0.05%
140,950
-19,225
-12% -$893K
WMT icon
368
Walmart Inc
WMT
$885B
$6.79M 0.05%
171,300
-11,700
-6% -$465K
MTCH icon
369
Match Group
MTCH
$9.19B
$6.74M 0.05%
82,025
-34,450
-30% -$2.51M
TGT icon
370
Target
TGT
$65.6B
$6.6M 0.04%
51,500
-3,500
-6% -$411K
OLED icon
371
Universal Display
OLED
$3.68B
$6.55M 0.04%
31,775
-4,550
-13% -$860K
SAFM
372
DELISTED
Sanderson Farms Inc
SAFM
$6.5M 0.04%
+36,900
New +$5.83M
SIVB
373
DELISTED
SVB Financial Group
SIVB
$6.36M 0.04%
+25,325
New +$5.76M
UMPQ
374
DELISTED
Umpqua Holdings Corp
UMPQ
$6.34M 0.04%
358,200
-3,700
-1% -$61.2K
CBRE icon
375
CBRE Group
CBRE
$42.5B
$6.15M 0.04%
100,385
-7,200
-7% -$399K

Similar funds

Carillon Tower Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Carillon Tower Advisers held 499 positions worth $15B, up 4.3% from $14.4B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Carillon Tower Advisers withdrew a net $689M in Q4 2019, closing 34 positions and reducing 287 holdings. Its most notable exit was Insulet, an estimated $86.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carillon Tower Advisers opened a new position in Seagen Inc. Common Stock worth $48.8M.

  • Carillon Tower Advisers's largest Q4 2019 buy was Seagen Inc. Common Stock: 426,867 shares worth $48.8M.
  • Carillon Tower Advisers added most to Corpay in Q4 2019, an estimated $58.8M increase.
  • Carillon Tower Advisers's biggest Q4 2019 reduction was WEC Energy, cutting an estimated $49.5M.
  • Carillon Tower Advisers fully exited Insulet in Q4 2019, selling an estimated $86.4M.
  • Carillon Tower Advisers's ten largest holdings make up 9.9% of its $15B portfolio in Q4 2019.
  • Carillon Tower Advisers opened 33 new positions and closed 34 in Q4 2019.
  • Carillon Tower Advisers's portfolio value rose 4.3% quarter-over-quarter to $15B.

Based on Carillon Tower Advisers's 13F filing for Q4 2019, filed 11 Feb 2020.